Name of bioresource/bank
Alzheimer’s CSF biobank
Name of Principal Investigator
| Title | Professor |
| First name | Kaj |
| Last name | Blennow |
Address of institution where award is held
| Institution | Neuroscience and Physiology |
| Street Address | Sahlgrenska University Hospital |
| City | |
| Postcode | S-431 80 |
Country
Sweden
Website
http://www.neurophys.gu.se/sektioner/psykiatri_och_neurokemi/neurokem/
Contact email (e.g. manager or coordinator)
Funding source
1) Swedish Research Council
2) Alzheimer’s Association
Q1 What conditions does your resource cover?
Alzheimer’s disease and other dementias
Q2a What DNA collection does your resources hold?
101-1000 donors
Q2b What cell lines does your resource hold?
1-50 distinct cell lines
Q2c What tissue (including post-mortem tissue) does your resource hold?
None
Q3 Are human tissues/samples/DNA from
Living donors:blood Living donors: cerebro-spinal fluid
Q4 Are tissues/samples/DNA from
Healthy individuals/control donors Patients
Q5 Can samples be linked to clinical (phenotypic) information and if so, is this information:
Not linked to clinical information In a specific study-associated dataset Collected as part of a specific clinical trial(s)
Q6 In what form are samples supplied?
Primary Samples: Stabilised samples (frozen or fixed)
Q7 Are biomarkers/analytes/biological characteristics already measured and the information available for your samples?
In most samples
Q8 What is the status of your tissue/sample/DNA collection?
Q9 What are the rules and procedures for access?
Apply to PI or co-ordinator at resource